Business Context and Reporting Period
Kulicke & Soffa Industries, Inc. (K&S) designs, manufactures, and markets capital equipment and expendable tools for semiconductor assembly. This Form 10-Q covers the quarterly period ended June 27, 2009 (the third quarter of fiscal 2009). The company operates two primary segments: Equipment (ball bonders, wedge bonders, die bonders) and Expendable Tools (capillaries, wedge tools, saw blades). The reporting period reflects significant strategic shifts, including the sale of the Wire business (reported as discontinued operations) and the acquisition of Orthodyne Electronics Corporation.
Key Financial Metrics
| Metric | Three Months Ended June 27, 2009 | Nine Months Ended June 27, 2009 |
|---|---|---|
| Net Revenue | $52.1 million | $114.7 million |
| Gross Profit | $19.7 million (37.8% margin) | $41.6 million (36.3% margin) |
| Loss from Continuing Operations | $(14.5) million | $(81.6) million |
| Net Loss | $(13.9) million | $(42.5) million |
| Cash and Cash Equivalents | $114.7 million | $114.7 million (as of period end) |
| Total Debt | $159.0 million | $159.0 million (as of period end) |
| Operating Cash Flow (Continuing) | Not provided for quarter | $(41.2) million used |
Material Changes vs. Prior Period
- Revenue Decline: Net revenue for the nine months ended June 27, 2009, decreased 57.0% to $114.7 million compared to $266.8 million in the prior year period. This was driven by a 65.1% drop in Equipment revenue due to the global economic crisis and reduced semiconductor demand.
- Segment Performance: The Equipment segment reported an operating loss of $81.9 million for the nine months, compared to a loss of $12.7 million in the prior year. The Expendable Tools segment remained relatively stable, reporting a small operating profit of $0.3 million.
- Acquisition Impact: The acquisition of Orthodyne in Q1 2009 added wedge bonder equipment and tools revenue, partially offsetting volume declines in legacy product lines. Goodwill increased by $26.7 million due to this acquisition.
- Discontinued Operations: The company sold its Wire business in September 2008. The nine-month period included a net gain of $22.7 million from this sale, which significantly mitigated the overall net loss.
- Impairment Charges: A non-cash goodwill impairment charge of $2.7 million was recorded in Q1 2009 related to the end-of-life of EasyLine and SwissLine die bonders.
Guidance, Outlook, and Risks
- Outlook: Management expects net revenue for the fourth quarter (ending October 3, 2009) to be approximately $85 million to $90 million, citing improved factory utilization and increased customer orders. However, visibility beyond the current quarter is limited.
- Cost Reductions: The company implemented workforce reductions totaling approximately 490 employees (20% of total workforce) and wage reductions of 5% to 20% to minimize cash usage. Manufacturing is being consolidated, with Israel operations transferring to Suzhou, China.
- Liquidity: Cash and investments decreased by $68.8 million year-over-year due to the Orthodyne acquisition ($87.0 million), debt repurchases ($84.4 million), and tax settlements ($14.7 million), partially offset by Wire business proceeds ($155.0 million). Management believes existing reserves are sufficient for the next 12 months.
- Risks: Key risks include the high volatility of the semiconductor industry, foreign currency fluctuations (notably in Israel, Malaysia, Singapore, and Switzerland), and the potential need for additional financing if economic conditions remain weak.
- Tax Contingencies: The company settled a significant tax dispute in Israel for $12.5 million, recognizing a $12.4 million tax benefit in the period. An IRS audit for the period ended September 30, 2006, remains ongoing.
Investor Verification Checklist
- Revenue Visibility: Verify the sustainability of the projected $85-$90 million Q4 revenue given the historical volatility of the semiconductor equipment market.
- Debt Structure: Review the terms of the remaining $159 million in Convertible Subordinated Notes (maturing 2010 and 2012) and the company's ability to refinance or repay them.
- Integration Costs: Monitor the integration progress and cost synergies of the Orthodyne acquisition versus the ongoing costs of transferring manufacturing from Israel to China.
- Inventory Levels: Assess the $42.1 million inventory balance against the backdrop of declining sales volumes to ensure reserves for obsolescence are adequate.
- Discontinued Operations: Confirm that the $22.7 million gain from the Wire business sale is fully realized and that no significant working capital adjustments remain in dispute with the buyer (Heraeus).